Research Article
Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer
Table 2
Positive rate of plasma mSEPT9 in each enrolled group using 2/3 algorithm.
| Characteristics | N | mSEPT9 | value | value | N | % |
| CRC | 98 | 60 | 61.2 | <0.001 | Ref. | Adenomas | 101 | 8 | 7.9 | 0.006 | <0.001 | Noncolorectal cancer | 76 | 15 | 19.7 | <0.001 | <0.001 | Gastric cancer | 10 | 7 | 70.0 | | | Breast cancer | 58 | 8 | 13.8 | | | Other cancer | 8 | 0 | 0.0 | | | Inflammation | 30 | 2 | 6.7 | 0.125 | <0.001 | Gastroenteritis | 26 | 2 | 7.7 | | | Other Inflammation | 4 | 0 | 0.0 | | | NED | 253 | 4 | 1.6 | Ref. | <0.001 |
|
|
CRC: colorectal cancer; NED: no evidence of diseases; : compared with NED (ref.); : compared with CRC (ref.). |